• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

12
12
12
12
4

COUNTRY

12

CATEGORIES

  • 11
  • 5
  • 4
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

9
10
21
29

PUBLISHED

0
4
9
29

PRODUCT TYPE

23
6

Search "China Company Research - Jiangsu Hengrui Medicine Co., Ltd " returned 29 results.

Jiangsu Hengrui Medicine Co., Ltd. (600276) - Financial and Strategic SWOT Analysis Review

Jiangsu Hengrui Medicine Co., Ltd. (600276) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has...

May 2015
FROM
Investigation Report on China Tegafur, Gimeracil and Oteracil (Tegafur/gimeracil/oteracil) Market, 2010-2019 Investigation Report on China Tegafur, Gimeracil and Oteracil (Tegafur/gimeracil/oteracil) Market, 2010-2019 - Product Thumbnail Image

Investigation Report on China Tegafur, Gimeracil and Oteracil (Tegafur/gimeracil/oteracil) Market, 2010-2019

Tegafur, gimeracil and oteracil (Tegafur/gimeracil/oteracil), a fluorouracil derivative, is an oral biological anti-cancer agent made up of tegafur (FT), gimeracil (CDHP) and oteracil (Oxo). In 1999,...

June 2015
FROM
Research Report on Top 50 Companies of China's Pharmaceutical Industry, 2011-2012 Research Report on Top 50 Companies of China's Pharmaceutical Industry, 2011-2012 - Product Thumbnail Image

Research Report on Top 50 Companies of China's Pharmaceutical Industry, 2011-2012

" Since 2006, the proportion of China pharmaceutical industry output in GDP has remained stable In the past five years, the proportion fell slightly in 2007, while in other years it kept a growth trend...

November 2011
FROM
Investigation Report on China Tropisetron Market, 2010-2019 Investigation Report on China Tropisetron Market, 2010-2019 - Product Thumbnail Image

Investigation Report on China Tropisetron Market, 2010-2019

Cancer patients are afraid of such adverse reactions as nausea and emesis caused by chemotherapy. Severe nausea and vomiting will make future chemotherapy a daunting experience for patients. They may...

June 2015
FROM

Research and Development Forecast of China Contrast Media (Contrast Agent) Market, 2014

With the mushroom growth of world diagnostic imaging equipments and apparatuses, as for X-CT contrast media, iodinated contrast media serving as the main one is witnessing unprecedented development...

January 2014
FROM

Research and Development Forecast of China Contrast Media (Contrast Agent) Market, 2014

With the mushroom growth of world diagnostic imaging equipments and apparatuses, as for X-CT contrast media, iodinated contrast media serving as the main one is witnessing unprecedented development...

January 2014
FROM
Research Report on Top 100 Enterprises in Chinese Pharmaceutical Industry, 2009-2010 Research Report on Top 100 Enterprises in Chinese Pharmaceutical Industry, 2009-2010 - Product Thumbnail Image

Research Report on Top 100 Enterprises in Chinese Pharmaceutical Industry, 2009-2010

In 2008, the sales of Chinese pharmaceutical industry amounted to RMB 677 776 billion, rising by over 20% YOY Among the sub-industries, the sales growth rate of the biological product industry was 31...

December 2009
FROM
Research Report on Chinese Chemical Pharmaceutical Industry 2010-2011 Research Report on Chinese Chemical Pharmaceutical Industry 2010-2011 - Product Thumbnail Image

Research Report on Chinese Chemical Pharmaceutical Industry 2010-2011

In China, the chemical pharmaceutical industry includes the chemical API industry and the chemical preparation industry The chemical active pharmaceutical ingredients (API) manufacture refers to the...

October 2010
FROM
Investigation Report on China Tegafur, Gimeracil and Oteracil (Tegafur/gimeracil/oteracil) Market, 2010-2019 Investigation Report on China Tegafur, Gimeracil and Oteracil (Tegafur/gimeracil/oteracil) Market, 2010-2019 - Product Thumbnail Image

Investigation Report on China Tegafur, Gimeracil and Oteracil (Tegafur/gimeracil/oteracil) Market, 2010-2019

Tegafur, gimeracil and oteracil (Tegafur/gimeracil/oteracil), a fluorouracil derivative, is an oral biological anti- cancer agent made up of tegafur (FT), gimeracil (CDHP) and oteracil (Oxo). In 1999,...

December 1899
FROM

Nasopharyngeal Cancer Global Clinical Trials Review, H1, 2014

Nasopharyngeal Cancer Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Nasopharyngeal Cancer Global Clinical Trials Review, H1, 2014" provides data on the Nasopharyngeal...

March 2014
FROM

Anesthetic Effect - Pipeline Review, H1 2015

‘Anesthetic Effect - Pipeline Review, H1 2015’, provides an overview of the Anesthetic Effect’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development...

April 2015
FROM

Throat Cancer Global Clinical Trials Review, H2, 2013

Throat Cancer Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Throat Cancer Global Clinical Trials Review, H2, 2013" provides data on the Throat Cancer clinical trial scenario....

November 2013
FROM

Chemotherapy Induced Neutropenia - Pipeline Review, H2 2014

Chemotherapy Induced Neutropenia - Pipeline Review, H2 2014 Summary This, ‘Chemotherapy Induced Neutropenia - Pipeline Review, H2 2014’, provides an overview of the Chemotherapy Induced Neutropenia’s...

November 2014
FROM
Investigation Report on China Tropisetron Market, 2010-2019 Investigation Report on China Tropisetron Market, 2010-2019 - Product Thumbnail Image

Investigation Report on China Tropisetron Market, 2010-2019

Cancer patients are afraid of such adverse reactions as nausea and emesis caused by chemotherapy. Severe nausea and vomiting will make future chemotherapy a daunting experience for patients. They may...

December 1899
FROM

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999) - Financial and Strategic SWOT Analysis Review

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations....

June 2013
FROM
Company Study of Jiangsu Hengrui Medicine Co, Ltd., 2007 Company Study of Jiangsu Hengrui Medicine Co, Ltd., 2007 - Product Thumbnail Image

Company Study of Jiangsu Hengrui Medicine Co, Ltd., 2007

Jiangsu Hengrui Medicine Co., Ltd. mainly produces anti-tumor drugs, anti-infectious drugs, antibiotic drugs and drugs for operation, and the first kind generates most of the companys profit. In the...

June 2007
FROM
Company Study of Jiangsu Hengrui Medicine Co, Ltd. 2007 Company Study of Jiangsu Hengrui Medicine Co, Ltd. 2007 - Product Thumbnail Image

Company Study of Jiangsu Hengrui Medicine Co, Ltd. 2007

Jiangsu Hengrui Medicine Co., Ltd. mainly produces anti-tumor drugs, anti-infectious drugs, antibiotic drugs and drugs for operation, and the first kind generates most of the companys profit. In the...

June 2007
FROM

Chemotherapy Induced Neutropenia - Pipeline Review, H1 2014

Chemotherapy Induced Neutropenia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Chemotherapy Induced Neutropenia - Pipeline Review, H1 2014’, provides an overview of the Chemotherapy...

June 2014
FROM

Hubei Qianjiang Pharmaceutical, Ltd.

A textual analysis of the financial results for Hubei Qianjiang Pharmaceutical, Ltd. compared to selected competitors. Also included are quantitative analyses of the company's financial statements,...

March 2015
FROM
Research Report of Chinese Off-patent Drug Market, 2009 Research Report of Chinese Off-patent Drug Market, 2009 - Product Thumbnail Image

Research Report of Chinese Off-patent Drug Market, 2009

The off-patent drugs refer to a kind of copy drug, which have the same dosage, security, strength, quality, performance and intended uses to the commercial name drugs The legal acquirement of the off-patent...

April 2009
FROM
Loading Indicator

Our Clients

Abbott Laboratories Ltd. Ford Motor Company Honeywell International, Inc. Nike, Inc. Deloitte LLP. IMAX Corporation